Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:48:00 EDT Wed 01 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:BMRN
- BIOMARIN PHARMACEUTICAL -
http://www.biomarinpharm.com
11:48:00 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
BMRN
- Q
0.2
81.70
·
81.77
0.1
81.70
+0.94
1.2
382.0
30,763
5,382
81.07
82.205
80.91
99.56 76.02
11:28:01
Apr 24
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
Company
·
Participants
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 5382
More trades...
Time ET
Ex
Price
Change
Volume
11:28:11
Q
81.7147
0.9547
1
11:28:02
Q
81.71
0.95
10
11:28:02
Q
81.71
0.95
10
11:28:02
Q
81.71
0.95
52
11:28:02
Q
81.71
0.95
1
11:28:02
Q
81.71
0.95
1
11:28:02
Q
81.70
0.94
12
11:28:02
Q
81.70
0.94
57
11:28:02
Q
81.70
0.94
100
11:28:02
Q
81.70
0.94
33
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-24 16:03
U:BMRN
News Release
200
BioMarin Reports Record Financial Results for the First Quarter 2024
2024-04-10 08:00
U:BMRN
News Release
200
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
2024-03-12 08:30
U:BMRN
News Release
200
New Data to be Presented for BioMarin's VOXZOGO(TM) (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
2024-03-07 08:30
U:BMRN
News Release
200
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
2024-03-01 09:00
U:BMRN
News Release
200
BioMarin Scheduled to Participate in March Investor Conferences
2024-02-22 16:03
U:BMRN
News Release
200
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
2024-02-08 08:00
U:BMRN
News Release
200
BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET
2024-02-06 08:30
U:BMRN
News Release
200
BioMarin to Present ROCTAVIAN ¢ „ ¢ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress
2024-01-03 08:00
U:BMRN
News Release
200
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA
2023-12-20 16:05
U:BMRN
News Release
200
BioMarin Announces Governance Enhancements and Value Creation Initiatives
2023-11-28 08:30
U:BMRN
News Release
200
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN ‚ ® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Germany
2023-11-01 16:05
U:BMRN
News Release
200
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year
2023-11-01 16:02
U:BMRN
News Release
200
BioMarin Announces Retirement of Jean-Jacques Bienaim ƒ ©; Appoints Alexander Hardy President and Chief Executive Officer
2023-10-20 16:05
U:BMRN
News Release
200
U.S. Food and Drug Administration Approves BioMarin's VOXZOGO ‚ ® (vosoritide) for Children Under 5 Years with Achondroplasia
2023-10-17 08:30
U:BMRN
News Release
200
BioMarin to Host Third-Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, November 1, at 4:30pm ET
2023-09-21 10:00
U:BMRN
News Release
200
BioMarin to Present Data Showing Long-Term Benefit of VOXZOGO ‚ ® (vosoritide) on Growth in Children with Achondroplasia at 2023 European Society for Paediatric Endocrinology (ESPE) Meeting
2023-09-15 09:29
U:BMRN
News Release
200
BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO ‚ ® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia
2023-09-11 08:30
U:BMRN
News Release
200
BioMarin to Present Innovative Pipeline at R&D Day on September 12th in New York
2023-09-06 08:30
U:BMRN
News Release
200
BioMarin to Present Pipeline at Upcoming R&D Day on Tuesday, September 12th
2023-09-05 08:30
U:BMRN
News Release
200
BioMarin to Participate in Three Upcoming Investor Conferences